A Phase 2, Randomized, Double-Blind, Placebo- Controlled Study of Chemo-Immunotherapy Combination using Motolimod with Pegylated Liposomal Doxorubicin in Recurrent Or Persistent Ovarian Cancer: A Gynecologic Oncology Group Partners Study

No Thumbnail Available

Authors

Monk, B. J.
Brady, M. F.
Aghajanian, C.
Lankes, H. A.
Rizack, T.
Leach, J.
Fowler, J. M.
Higgins, R.
Hanjani, P.
Morgan, M.

Issue Date

2017

Type

Journal Article

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Description

Citation

Monk, B. J.; Brady, M. F.; Aghajanian, C.; Lankes, H. A.; Rizack, T.; Leach, J., et al. (2017). A Phase 2, Randomized, Double-Blind, Placebo- Controlled Study of Chemo-Immunotherapy Combination using Motolimod with Pegylated Liposomal Doxorubicin in Recurrent Or Persistent Ovarian Cancer: A Gynecologic Oncology Group Partners Study. Ann Oncol, May 1 2017, 28(5):996-1004. doi: http://dx.doi.org/10.1093/annonc/mdx049

Publisher

License

Journal

Volume

Issue

PubMed ID

DOI

ISSN

1569-8041
0923-7534

EISSN